Article published in Pharmaceutics by Coppes group

28 March 2024
Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer.
Zanten JV, Jorritsma-Smit A, Westra H, Baanstra M, Bruin-Jellema A, Allersma D, Gareb B, Coppes RP.
Pharmaceutics. 2024 Mar 21;16(3):435. doi: 10.3390/pharmaceutics16030435.
Back to previous page